For many individuals living with depression, treatment begins with therapy, antidepressant medication, or a combination of both. These approaches can be very effective, but some people continue to experience significant symptoms despite appropriate care. Depression may improve only partially, symptoms may return after periods of stability, or medications may stop working as effectively over time. When this occurs, clinicians often begin to consider whether a different treatment strategy may be needed.
In recent years, psychiatric medicine has introduced new treatment options for individuals whose depression has been difficult to treat with conventional medications. Ketamine-based treatments are one example. By affecting different brain pathways than traditional antidepressants, ketamine therapy may offer another option for individuals whose depression has not improved adequately with standard treatment strategies.
Ketamine therapy refers to the use of ketamine in a supervised medical setting as part of treatment for certain forms of depression. Originally developed as an anesthetic medication, ketamine has been studied for its effects on brain systems involved in mood regulation. In mental health care, ketamine-based treatments are typically considered when depression has not improved with conventional antidepressant medications.
Ketamine acts on the brain’s glutamate system, which plays an important role in how brain cells communicate with one another. Glutamate is the most abundant excitatory neurotransmitter in the brain and is involved in learning, memory, and emotional processing. By influencing glutamate receptors, ketamine affects the signaling pathways that help regulate neural activity and brain connectivity. This mechanism differs from traditional antidepressants, which primarily target serotonin or norepinephrine systems.
Research suggests that ketamine may influence neural pathways involved in mood regulation and emotional processing. Changes in these pathways may help support the brain’s ability to adapt and form new neural connections, processes often referred to as brain plasticity. In individuals with persistent depression, these neural systems may not function as efficiently, which can contribute to ongoing symptoms. By affecting these pathways, ketamine-based treatments may offer another approach for individuals whose depression has not responded adequately to conventional therapies.
Most antidepressant medications work by gradually increasing levels of neurotransmitters such as serotonin, norepinephrine, or dopamine, and they often take several weeks before noticeable improvement occurs. Ketamine works through a different biological pathway involving the brain’s glutamate system, which influences how brain cells communicate and adapt. Because this mechanism differs from traditional antidepressants, ketamine-based treatments may offer another therapeutic option for individuals whose depression has not improved with conventional medications.
Ketamine and esketamine are closely related medications, but they are not identical. Ketamine is the original compound that has been used for decades in medical settings as an anesthetic and has more recently been studied for its potential role in treating depression. Esketamine is a modified form of ketamine that contains one specific component of the ketamine molecule and is used in certain prescription treatments for depression.
Esketamine is available as the medication Spravato, which is administered as a nasal spray in certified treatment settings under medical supervision. Both ketamine and esketamine affect glutamate pathways in the brain, but they are delivered through different treatment protocols and may be used in different clinical contexts. Understanding the distinction between these therapies helps patients and clinicians determine which treatment approach may be most appropriate based on individual needs and treatment history.
Ketamine-based treatments may be considered for individuals whose depression has not improved with conventional treatment approaches. A clinical evaluation helps determine whether this type of therapy may be appropriate based on symptoms, treatment history, and overall mental health needs.
Ketamine-based treatment is often explored for individuals diagnosed with treatment-resistant depression, which typically refers to depression that has not improved after trying multiple antidepressant medications at appropriate doses and durations. People in this situation may continue to experience symptoms such as persistent sadness, fatigue, low motivation, or difficulty concentrating despite ongoing treatment. Traditional antidepressants primarily affect serotonin or related neurotransmitter systems, which may not fully address every form of depression. Because ketamine influences the brain’s glutamate pathways, it may offer an alternative treatment option when conventional medications have not produced meaningful improvement.
Some individuals experience only partial improvement with antidepressant medication and continue to struggle with ongoing depressive symptoms. Mood may improve somewhat, yet fatigue, emotional numbness, or difficulty concentrating may still affect daily functioning. In these cases, depression may not meet the strict definition of treatment-resistant depression but can still be difficult to manage with medication alone. Ketamine-based therapies may sometimes be considered when symptoms remain despite ongoing antidepressant treatment. A comprehensive psychiatric evaluation helps determine whether this approach may be appropriate within a broader treatment plan.
Ketamine-based treatments are delivered within a structured clinical program designed to ensure safety and appropriate monitoring. Because the medication can temporarily affect perception, awareness, and blood pressure, treatment must take place in a supervised medical setting. Each step of the process is carefully guided by trained clinical staff.
Ketamine treatment is administered during scheduled appointments in a clinical environment. The medication is delivered according to established medical protocols while patients remain under the supervision of trained staff. The setting is designed to be calm and supportive while the medication takes effect. Because ketamine can cause temporary changes in perception or alertness, patients remain in the clinic for observation following administration.
After receiving the medication, patients remain under observation while the treatment takes effect. Clinical staff monitor patients throughout this period and check vital signs such as blood pressure. Some individuals may experience temporary sensations such as dizziness, dissociation, or drowsiness during treatment. Supervised monitoring helps ensure that these effects resolve safely before patients leave the clinic.
Ketamine-based treatment is typically delivered in a series of sessions during an initial phase, followed by additional sessions depending on individual response. The treatment schedule allows clinicians to observe how symptoms change over time and make adjustments when necessary. Follow-up visits also help ensure that ketamine therapy remains integrated into a broader depression treatment plan.
Ketamine-based treatment is typically considered as one component of a comprehensive depression care plan. While the therapy may help improve depressive symptoms, long-term mental health stability often involves addressing the biological, psychological, and lifestyle factors that influence mood. Integrating ketamine treatment into a comprehensive care plan helps ensure that therapy supports both symptom relief and overall mental health.
At Willow & Stone, ketamine-based treatments are evaluated within the context of each patient’s full clinical picture. Medication strategies, therapy, lifestyle patterns, and other aspects of mental health care are considered together when developing a personalized plan. This integrative approach allows treatment to focus not only on symptom improvement but also on the underlying factors that may be contributing to persistent depression.
Willow & Stone provides integrative psychiatric care for individuals experiencing depression throughout the Dallas–Fort Worth area, with an office located in Arlington. Patients across the broader DFW region—including Dallas, Fort Worth, Mansfield, and surrounding communities—can access in-person care for treatments that require clinical supervision. We also offer secure telehealth appointments across Texas for psychiatric evaluation, treatment planning, and follow-up care when appropriate.
Many patients come to Willow & Stone after feeling that previous treatment experiences focused mainly on medication changes without fully exploring the factors influencing their depression. Our approach is designed to provide thoughtful, individualized psychiatric care that considers the broader context of mental health.
Care begins with a detailed psychiatric evaluation that reviews symptoms, treatment history, and overall health. This process helps clinicians understand how depression has developed over time and how previous treatments have affected symptoms. Taking time to explore these details often provides important insight into why depression has been difficult to treat.
Treatment planning considers the biological, psychological, and lifestyle factors that influence mood and emotional health. This integrative approach helps ensure that care addresses more than symptoms alone. Medication strategies, mental health support, and overall health considerations are evaluated together when developing a treatment plan.
Depression affects each person differently, and treatment strategies often need to reflect those differences. Care plans are developed collaboratively with attention to symptoms, treatment history, and personal goals. This allows treatment to evolve as progress becomes clearer and needs change over time.
Persistent depression can feel discouraging, particularly when previous treatments have not produced lasting improvement. However, ongoing symptoms often signal that additional factors affecting mental health may need to be explored. With careful evaluation and a comprehensive approach to care, new treatment pathways may become available that support more stable and lasting recovery.
